Invesco Advisers, Inc., a subsidiary of Invesco Ltd. (NYSE: IVZ), announced today that, effective immediately, the Board of Trustees (“Board”) of each of Invesco High Income Trust II (NYSE: VLT) and Invesco Senior Income Trust (NYSE: VVR) (each, a “Fund” and collectively, the “Funds”) terminated the Managed Distribution Plan for each Fund (individually, the “VLT […]

Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, announced today thatJeffrey M. Ettinger, chairman of The Hormel Foundation, has been re-appointed to the Hormel Foods Board of Directors, effectiveMarch 21, 2025. The Hormel Foundation, an unaffiliated non-profit organization with a charitable mission, beneficially owns approximately 46% of Hormel Foods outstanding common

(NYSE:EBS), GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, today announced that its Compensation Committee has granted an equity award to a newly hired employee under its 2023 Inducement Plan (the “Inducement Plan”). The employee

Toronto, ON, March 20, 2025 (GLOBE NEWSWIRE) — Toronto, ON – March 20, 2025 – In times of economic uncertainty, Canadians need more than just financial guidance–they need financial protection. Yet under current laws, anyone–regardless of education, training, or ethical standards–can call themselves a financial advisor. As inflation, housing instability, and retirement insecurity mount, the

Tallahassee, FL, March 20, 2025 (GLOBE NEWSWIRE) — ShibaDino has announced its platform, a thrilling addition to the meme coin space. Unlike most meme coins, it is designed to offer utility and fun. Committed to going beyond the mere hype meme coins are known for, the ShibaDino ecosystem offers excitement with purpose. The project combines

(NASDAQ:BRTX), MELVILLE, N.Y., March 20, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that it will release its 2024 financial results after market close on Thursday, March 27, 2025. Following the announcement, BioRestorative management will

(NASDAQ:DYN), WALTHAM, Mass., March 20, 2025 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced it has granted inducement equity awards to its newly appointed Chief Financial Officer, Erick J. Lucera. The awards were approved by the Compensation

(NasdaqGM:BIOA), Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25 Progression of preclinical next-generation APJ agonists for obesity New platform partnerships with Novartis and Lilly to discover and develop novel therapies for conditions driven by metabolic aging RICHMOND, Calif., March 20, 2025 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (“BioAge”, “the Company”),

(NYSE:GTN),(NYSE:GTN-A), ATLANTA, March 20, 2025 (GLOBE NEWSWIRE) — Gray Media has named Jaime Sayre Kawaja as General Manager and Director of Sales for WKYT and WYMT, which together serve as the CBS affiliates for the Lexington/Hazard, Kentucky, television market. Effective April 1, she will succeed Jeff Anderson, who recently announced his decision to pursue new

(NASDAQ:CROX), SAN FRANCISCO, March 20, 2025 (GLOBE NEWSWIRE) — Investors in Crocs, Inc. (NASDAQ: CROX) suffered yet another loss on Oct. 29, 2024 after the company prepared investors for disappointing Q4 and FY 2024 financial results that, in turn, sent shares crashing $26.47 (-19%). According to the company, the culprit was its HEYDUDE operating segment